| Holding(s) in Company | 27-Oct-2025 | 15:37 | RNS |
| Strategic review and consideration of AIM listing | 22-Oct-2025 | 07:00 | RNS |
| Ascend Imaging agreement expansion | 06-Oct-2025 | 07:00 | RNS |
| University of Virginia Health Hospital agreement | 29-Sep-2025 | 07:00 | RNS |
| National Institutes of Health system order | 25-Sep-2025 | 12:14 | RNS |
| Half-year Report | 25-Sep-2025 | 07:00 | RNS |
| Notice of Results | 16-Sep-2025 | 07:00 | RNS |
| Holding(s) in Company | 11-Sep-2025 | 16:36 | RNS |
| Submission of new Phase III study protocol to FDA | 12-Aug-2025 | 07:00 | RNS |
| Block Listing Six Monthly Return | 24-Jul-2025 | 07:00 | RNS |
| Promotion & sales representative agreement | 24-Jun-2025 | 07:00 | RNS |
| Result of AGM | 09-Jun-2025 | 16:16 | RNS |
| FDA expands XENOVIEW indication | 02-Jun-2025 | 07:00 | RNS |
| Dr. Bastiaan Driehuys awarded by ATS | 21-May-2025 | 07:00 | RNS |
| Xenon MRI featured prominently at ATS 2025 | 15-May-2025 | 12:48 | RNS |
| Currency | UK Pounds |
| Share Price | 0.16p |
| Change Today | 0.005p |
| % Change | -3.13 % |
| 52 Week High | 1.65p |
| 52 Week Low | 0.14p |
| Volume | 13,853,590 |
| Shares Issued | 1,207.03m |
| Market Cap | £1.87m |
| Beta | 0.11 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:57 | 2,000,000 @ 0.15p |
| 16:12 | 16,139 @ 0.16p |
| 16:10 | 13,663 @ 0.15p |
| 16:10 | 2,500 @ 0.16p |
| 16:10 | 37,697 @ 0.15p |
| CFO | Charles Osborne |
| CEO | Christopher von Jako |
You are here: research